{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 14,
        "end": 17
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 100,
        "end": 109
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 121,
        "end": 135
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 138,
        "end": 148
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 151,
        "end": 161
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 164,
        "end": 171
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 182,
        "end": 193
      }
    },
    {
      "id": "T10",
      "obj": "Chemical",
      "span": {
        "begin": 198,
        "end": 208
      }
    },
    {
      "id": "T11",
      "obj": "Disease",
      "span": {
        "begin": 243,
        "end": 247
      }
    },
    {
      "id": "T12",
      "obj": "Chemical",
      "span": {
        "begin": 112,
        "end": 116
      }
    },
    {
      "id": "T13",
      "obj": "Disease",
      "span": {
        "begin": 55,
        "end": 59
      }
    },
    {
      "id": "T20",
      "obj": "Chemical",
      "span": {
        "begin": 69,
        "end": 89
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "24265703_7",
  "text": "In contrast , RB1 status did not affect sensitivity of TNBC cells to multiple other drugs including cisplatin ( CDDP ) , 5-fluorouracil , idarubicin , epirubicin , PRIMA-1 ( met ) , fludarabine and PD-0332991 , some of which are used to treat TNBC patients ."
}
